key: cord-0016373-36lizgru
authors: Pillai, Ashwin; Koduri, Krithikrishna; Gokhale, Yojana; Venkatesh, Mamatha
title: Auditing the efficacy of prophylactic measures against Covid-19 amongst Healthcare workers in India
date: 2021-03-28
journal: J Infect
DOI: 10.1016/j.jinf.2021.03.022
sha: cdea8159150e55672aa0dc28f3c6a92d98ce28d3
doc_id: 16373
cord_uid: 36lizgru

nan

The study included a total of 834 healthcare workers including general practitioners (GPs), specialists, nurses, dentists, para-clinical support staff, and practitioners of traditional(alternative) medicine. The mean age was 44.8±12.1 years. 498 had no comorbidities, 159 had hypertension, 129 were overweight, 92 were diabetic, 39 had preexisting pulmonary diseases (asthma/COPD), 19 were active smokers, 9 had hypothyroidism, 8 had ischemic heart disease. 97 respondents had 2 or more coexistent comorbidities, with an overlap between diabetes mellitus, overweight and hypertension being the most prevalent. 56 respondents (6.71%) tested positive for covid-19; and further 56 developed symptoms consistent with covid-19 but were swab-negative. 11 of those who tested positive required non-invasive ventilatory assistance. None required invasive ventilatory support.

We assessed the risk attributable to each of the recorded parameters in developing disease.

The proportional occurrence of covid-positivity amongst different specialties was compared (detailed in Table 1 ), using Internal Medicine and allied subspecialties as control, as this group constituted the largest cohort of respondents.

General practitioners were identified as the greatest-at-risk sub-group (Relative risk[RR]:3.09, 95% Confidence Intervals[CI] -1.58-6.04, p<0.001). The next highest-at-risk group was that of anaesthesiologists/intensivists.

The relative risk (RR) for developing swab-positive disease was as follows:

for HCQ use alone (RR: 1.63, p=0.20), use of alternative medicine alone (RR: 2.27, p=0.13) and for combined use of HCQ and alternative medicine (RR:1.8, p=0.18).

These findings were stratified based on the number of covid patients seen by practitioners per day into 3 groups: those seeing <5/day, 5-10/day and >10/day. The increased risk was statistically significant for the use of "alternative" prophylaxis amongst practitioners who saw between 5-10 covid patients per day (RR: 16.72, 95% CI: 2.06-135.27, p=0.008).

Exposure was also stratified based on the cumulative duration of exposure in a covid-replete setting as follows: <15 days, 15 days-1month, 1-3months and >3months. The risk of swabpositive disease increased statistically significantly in the subgroup of practitioners utilizing alternative medicine-based prophylaxis who were in such a setting for between 1-3 months (RR: 5.60, 95% CI: 1.48-21.14, p= 0.01).

When stratified to assess the effect of HCQ prophylaxis on preventing relatively severe disease manifestations (defined as any requirement of non-invasive ventilatory assistance[NIV]), no benefit was noted in this study population (RR for requiring NIV: 4.21, 95% CI: 0.26-67.02, p=0.30).

The study found no benefit to the use of any pharmaco-prophylactic agent, both singly and in combination. Indeed, there was a tendency towards an increased risk.

Summarily, this study supports the continued use of standard protective measures including continued use of n-95 masks, maintenance of physical distancing>1m from patients, when feasible, and advises against the use of pharmaco-prophylactic agents.

Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers

False-negative RT-PCR for COVID-19 and a diagnostic risk score: a retrospective cohort study among patients admitted to hospital

SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields